IMATINIB MESYLATE 400 MG TAB

imatinib mesylate
$6.5733per EA
High Outlier

Strength

400 mg/1

NDC

67877063430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

11/18/2020

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208302

On Market Since

2/1/2019

Pharmacological Classes

Kinase Inhibitor
Protein Kinase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-57.8%